IQVIA Holdings Inc. (IQV)

Market Cap	33.64B
Revenue (ttm)	15.41B
Net Income (ttm)	1.37B
Shares Out	176.10M
EPS (ttm)	7.49
PE Ratio	25.51
Forward PE	16.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,548,358
Open	193.62
Previous Close	194.01
Day's Range	190.76 - 195.51
52-Week Range	187.62 - 261.73
Beta	1.48
Analysts	Strong Buy
Price Target	251.00 (+31.39%)
Earnings Date	Feb 6, 2025

About IQV

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 9, 2013
• Employees: 88,000
• Stock Exchange: NYSE
• Ticker Symbol: IQV
• Website: https://www.iqvia.com

Financial Performance

In 2024, IQVIA Holdings's revenue was $15.41 billion, an increase of 2.81% compared to the previous year's $14.98 billion. Earnings were $1.37 billion, an increase of 1.10%.

Analyst Forecast

According to 17 analysts, the average rating for IQV stock is "Strong Buy." The 12-month stock price forecast is $251.0, which is an increase of 31.39% from the latest price.

Price Target

$251.0

(31.39% upside)

Analyst Consensus: Strong Buy